Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors With Statin for ACS Patients
NCT07736313
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
120
Enrollment
OTHER
Sponsor class
Conditions
Acute Coronary Syndromes
Interventions
DRUG:
PCSK9 inhibitor plus rosuvastatin 20 mg tab
DRUG:
Rosuvastatin 20 Mg Oral Tablet
Sponsor
Assiut University